Study finds genes influencing one's sensitivity to environment, symptoms of mental disorders likely to express
New Delhi, A study has uncovered genes that govern how sensitive one is about their environment, levels of which can influence symptoms they present of mental disorders.
An international team of researchers, led by those at King's College London, UK, analysed nearly 10,900 pairs of identical twins from 11 studies and examined how changes in sensitivity to environment can influence one's chances of presenting symptoms of ADHD, autism, anxiety and depression, psychosis and neuroticism.
Findings, published in the journal Nature Human Behaviour, show that genes related to molecules important for neurodevelopment, immune function and the central nervous system were related with autistic traits.
Genes that influence how one reacts to stress were found to be linked with depressive symptoms.
Further, genes involved in regulating catecholamines -- hormones, such as dopamine and adrenaline, involved in responding to stress -- were linked to psychotic-like experiences, the researchers found.
"Differences in individuals' sensitivity to life experiences can explain why the same negative or positive experiences may have varying effects on people's mental health, depending on their genetic make-up," first author Elham Assary, a postdoctoral researcher at King's College London, said.
An interaction between one's genes and their environment is considered to make up a diverse range of traits across species.
The 'nature vs nurture' debate in psychology is concerned about how much of an individual's characteristics is due to genetics (nature), and how much due to environment (nurture).
"Our findings suggest that specific genetic variants influence how environmental exposures impact psychiatric and neurodevelopmental symptoms," Assary said.
Studies often look at identical twins, as they carry almost entirely identical genetic material -- this would mean that differences in their characteristics would be more likely due to the environment they experience.
"Some people are more sensitive to their circumstances, and this can be positive in good circumstances but can make life more challenging than for others in stressful circumstances," senior author Thalia Eley, professor of developmental behavioural genetics at King's College London, UK, said.
However, discerning which genes are involved in determining what characteristics and symptoms one expresses has proved challenging, especially for complex psychological traits, the team said.
"We identified 13 genome-wide significant associations, including genes related to stress reactivity for depression, growth factor-related genes for autistic traits and catecholamine uptake-related genes for psychotic-like experiences," the authors wrote.
Results from the study "provide an important step forward in disentangling
gene-environment interactions
for psychiatric traits and provide a framework for similar investigations in other traits," senior author Patricia Munroe, professor of molecular medicine at Queen Mary University of London, UK, said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
26 minutes ago
- Hans India
Gut and oral bacteria linked to cognitive decline: Study
Bacteria in the mouth and gut may play a significant role in the progression of cognitive decline in Parkinson's disease, according to a study. Specific changes in the gut microbiome have been associated with the shift from mild memory issues to dementia, a common and distressing symptom of the disease. While Parkinson's is currently very difficult to diagnose in its early stages, these changes in the microbiome could potentially act as early warning signs of Parkinson's, said the researchers from King's College London. It may help doctors detect and treat the disease before symptoms become severe. 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases. Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage,' said Dr. Saeed Shoaie, group leader of the Quantitative Systems Biology (QTS) Lab at King's College London, UK. In the study, published in the journal Gut Microbes, researchers analysed gut and mouth bacteria collected from 228 samples of stool and saliva. This included two groups of patients with Parkinson's -- those with mild cognitive decline and those with dementia -- showing different stages of the disease. These were compared with a healthy control group with no Parkinson's diagnosis. The results showed clear differences in the types and functions of bacteria between the groups. In people with cognitive impairment, the gut contains more harmful bacteria, many of which likely come from the mouth. This process, known as 'oral-gut translocation,' involves oral bacteria moving into the gut, where they don't normally belong. These bacteria were found to release specific molecules known as virulence factors, toxins that can damage gut tissue, promote inflammation, and possibly affect the brain. 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow. But our findings suggest they may play an active role in worsening symptoms,' said Dr. Frederick Clasen, research associate at King's. Using artificial intelligence (AI), the team linked these toxins specifically to cognitive decline in Parkinson's. These tools helped pinpoint bacterial species and functions that weren't obvious by traditional analysis alone. 'These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's. In the future, they might also be targets for new treatments that protect the brain by changing the gut environment,' Dr. Clasen explained. The findings also highlight the importance of oral hygiene and nutrition in people with Parkinson's, especially as the disease progresses.
Time of India
18 hours ago
- Time of India
Anxiety is the most common mental health problem - here's how tech could help manage it
Cambridge: Anxiety disorders are the world's most common mental health problem. But it isn't always easy to get professional help, with long waiting lists in many countries. Worldwide, only about 28 per cent of people with anxiety receive treatment. The figure is similar for the UK, and in the US about 37 per cent receive a treatment. This is due to a number of factors such as lack of resources, including mental health staff, and stigma associated with mental health problems. But if you're struggling to get help, there are things you could try at home in the meantime - including some novel technologies. To understand how they work, let's first take a look at how anxiety is expressed in the brain and body. The symptoms of anxiety are cognitive and emotional as well as physiological. They can include trouble concentrating and making decisions, feeling irritable or tense and having heart palpitations or shaking. Trouble sleeping and feelings of panic or impending danger are also common. These symptoms often start in childhood and adolescence. Sadly, it frequently continues into adulthood, especially if untreated. There are many genetic and environmental factors involved in the development of anxiety. These can include competition and pressure at school, university or work or financial worries and lack of job security. Social isolation and loneliness are also common factors, often a result of retirement, home working or stemming from bullying or maltreatment in childhood. Such experiences may even rewire our brains. For example, our neuroimaging study has shown that maltreatment in childhood is linked to changes in the connectivity of the brain's centromedial amygdala, which plays a key role in processing emotions, including fear and anxiety, and the anterior insula, which processes emotion among other things. Anxiety is commonly associated with depression or other conditions, including attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder. During the COVID pandemic when the prevalence of anxiety and depression increased by 25 per cent, people with such neurodevelopmental conditions exhibited more emotional problems than others. According to the Children's Commissioner this is still on the rise with 500 children per day being referred to mental health services for anxiety, more than double the rate pre-pandemic. Researchers are still uncovering new ways for professionals to help treat such people. For example, in our recent study, we noticed that suicidal thoughts and depression were more common in children with anxiety who were also very impulsive. This could impact the treatments they receive. So the science of how to best treat anxiety is constantly moving forward. Tech solutions Unfortunately though, waiting lists for even receiving a diagnosis can sometimes take years. Neurotechnology can, at least in part, help fill the gap before symptoms get worse. There are a number of startup companies in the anxiety space, working on both hardware and software for anxiety management. Technology for managing anxiety is rapidly advancing, offering alternatives and complements to traditional therapies. Moonbird, for example, uses a handheld device that guides users through paced breathing with gentle physical movements. You essentially feel the device move in your hand and breathe along with it. Research has shown that such breathing can help the nervous system to reduce anxiety symptoms. The company Parasym influences brain regions involved in mood and stress regulation. People can use it by wearing a small device that applies mild electrical micro impulses running through the vagus nerve, which runs from the ears and downwards trough the neck and activates a key part of the nervous system. Neurovalens and Flow Neuroscience are exploring non-invasive brain stimulation, such as transcranial "direct current stimulation (tDCS)". This can be applied by using electrodes placed on the scalp to deliver a mild, constant electrical current to alter brain activity. These devices ultimately target the prefrontal cortex to support the regulation of emotions. One scientific review of tDCS studies in anxiety has concluded that some research clearly showed benefits of tDCS for treating anxiety symptoms, although larger scale and longer duration studies were needed. How we experience life events and feel or react to them also influences physiological functions such as our heart rate. You will have experienced how having a meaningful conversation creates a special connection between two people. This can actually manifest in the body as increased synchronisation of your heart rates and other functions. This is termed "physiological synchrony" and is thought to be important for positive social interaction. Unfortunately, in common conditions of anxiety, including social anxiety and postpartum maternal anxiety, heart rate can become less variable and therefore less able to synchronise. Therefore, a device that promotes physiological synchrony would be beneficial. The company LYEONS Neurotech is currently developing such a device, targeting anxiety, post-traumatic stress disorder and ADHD. On the digital side, Headspace offers structured meditation and cognitive behavioural therapy based programmes. Similarly, ieso offer typed text-based CBT therapy for mild to moderate anxiety and low mood. These platforms use guided meditation, breathing exercises and behavioural tools to help users build emotion resilience and reduce anxious thought patterns. Other emerging tools also include virtual reality, which is being explored for exposure therapy and immersive stress reduction, in particular. All these technologies have used scientific and medical information to offer diverse options that address both mind and body. If we can halt the trend towards increasing numbers of people suffering from anxiety and find ways to improve access to effective treatments, it will lead to a better quality of life for individuals and their families, improved productivity and wellbeing at work and promote a flourishing society.
NDTV
19 hours ago
- NDTV
How Tech Could Help Manage Anxiety - The Most Common Mental Health Problem
Cambridge: Anxiety disorders are the world's most common mental health problem. But it isn't always easy to get professional help, with long waiting lists in many countries. Worldwide, only about 28% of people with anxiety receive treatment. The figure is similar for the UK, and in the US about 37% receive a treatment. This is due to a number of factors such as lack of resources, including mental health staff, and stigma associated with mental health problems. But if you're struggling to get help, there are things you could try at home in the meantime – including some novel technologies. To understand how they work, let's first take a look at how anxiety is expressed in the brain and body. The symptoms of anxiety are cognitive and emotional as well as physiological. They can include trouble concentrating and making decisions, feeling irritable or tense and having heart palpitations or shaking. Trouble sleeping and feelings of panic or impending danger are also common. These symptoms often start in childhood and adolescence. Sadly, it frequently continues into adulthood, especially if untreated. There are many genetic and environmental factors involved in the development of anxiety. These can include competition and pressure at school, university or work or financial worries and lack of job security. Social isolation and loneliness are also common factors, often a result of retirement, home working or stemming from bullying or maltreatment in childhood. Such experiences may even rewire our brains. For example, our neuroimaging study has shown that maltreatment in childhood is linked to changes in the connectivity of the brain's centromedial amygdala, which plays a key role in processing emotions, including fear and anxiety, and the anterior insula, which processes emotion among other things. Anxiety is commonly associated with depression or other conditions, including attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder. During the COVID pandemic when the prevalence of anxiety and depression increased by 25%, people with such neurodevelopmental conditions exhibited more emotional problems than others. According to the Children's Commissioner this is still on the rise with 500 children per day being referred to mental health services for anxiety, more than double the rate pre-pandemic. Researchers are still uncovering new ways for professionals to help treat such people. For example, in our recent study, we noticed that suicidal thoughts and depression were more common in children with anxiety who were also very impulsive. This could impact the treatments they receive. So the science of how to best treat anxiety is constantly moving forward. Tech Solutions Unfortunately though, waiting lists for even receiving a diagnosis can sometimes take years. Neurotechnology can, at least in part, help fill the gap before symptoms get worse. There are a number of startup companies in the anxiety space, working on both hardware and software for anxiety management. Technology for managing anxiety is rapidly advancing, offering alternatives and complements to traditional therapies. Moonbird, for example, uses a handheld device that guides users through paced breathing with gentle physical movements. You essentially feel the device move in your hand and breathe along with it. Research has shown that such breathing can help the nervous system to reduce anxiety symptoms. The company Parasym influences brain regions involved in mood and stress regulation. People can use it by wearing a small device that applies mild electrical micro impulses running through the vagus nerve, which runs from the ears and downwards trough the neck and activates a key part of the nervous system. Neurovalens and Flow Neuroscience are exploring non-invasive brain stimulation, such as transcranial 'direct current stimulation (tDCS)'. This can be applied by using electrodes placed on the scalp to deliver a mild, constant electrical current to alter brain activity. These devices ultimately target the prefrontal cortex to support the regulation of emotions. One scientific review of tDCS studies in anxiety has concluded that some research clearly showed benefits of tDCS for treating anxiety symptoms, although larger scale and longer duration studies were needed. How we experience life events and feel or react to them also influences physiological functions such as our heart rate. You will have experienced how having a meaningful conversation creates a special connection between two people. This can actually manifest in the body as increased synchronisation of your heart rates and other functions. This is termed 'physiological synchrony' and is thought to be important for positive social interaction. Unfortunately, in common conditions of anxiety, including social anxiety and postpartum maternal anxiety, heart rate can become less variable and therefore less able to synchronise. Therefore, a device that promotes physiological synchrony would be beneficial. The company LYEONS Neurotech is currently developing such a device, targeting anxiety, post-traumatic stress disorder and ADHD. On the digital side, Headspace offers structured meditation and cognitive behavioural therapy based programmes. Similarly, ieso offer typed text-based CBT therapy for mild to moderate anxiety and low mood. These platforms use guided meditation, breathing exercises and behavioural tools to help users build emotion resilience and reduce anxious thought patterns. Other emerging tools also include virtual reality, which is being explored for exposure therapy and immersive stress reduction, in particular. All these technologies have used scientific and medical information to offer diverse options that address both mind and body. If we can halt the trend towards increasing numbers of people suffering from anxiety and find ways to improve access to effective treatments, it will lead to a better quality of life for individuals and their families, improved productivity and wellbeing at work and promote a flourishing society. (Authors: Barbara Jacquelyn Sahakian, Professor of Clinical Neuropsychology, University of Cambridge and Christelle Langley, Postdoctoral Research Associate, Cognitive Neuroscience, University of Cambridge) (Disclosure Statement: Barbara Jacquelyn Sahakian receives funding from the Wellcome Trust. Her research work is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health and Neurodegeneration Themes. Christelle Langley receives funding from the Wellcome Trust. Her research work is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health and Neurodegeneration Themes.)
